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The AMP-activated protein kinase (AMPK) activates
autophagy, but its role in aging and fasting-induced
muscle function has not been defined. Here we
report that fasting mice lacking skeletal muscle
AMPK (AMPK-MKO) results in hypoglycemia and
hyperketosis. This is not due to defective fatty
acid oxidation, but instead is related to a block in
muscle proteolysis that leads to reduced circulating
levels of alanine, an essential amino acid required
for gluconeogenesis. Markers of muscle autophagy
including phosphorylation of Ulk1 Ser555 and Ser757
and aggregation of RFP-LC3 puncta are impaired.
Consistent with impaired autophagy, aged AMPK-
MKO mice possess a significant myopathy charac-
terized by reduced muscle function, mitochondrial
disease, and accumulation of the autophagy/
mitophagy proteins p62 and Parkin. These findings
establish an essential requirement for skeletal mus-
cle AMPK-mediated autophagy in preserving blood
glucose levels during prolonged fasting as well as
maintaining muscle integrity and mitochondrial
function during aging.
INTRODUCTION
The healthcare costs of both age-related muscle wasting ($18
billion) and the loss of muscle strength ($10 billion) are well
established, with severe consequences for rates of permanent
disability andmortality in the elderly (Janssen et al., 2004). These
statistics are set to rise with an expanding aging population, yet
there is still no known treatment for age-related muscle dysfunc-
tion and myopathy besides exercise. Additionally, it is often
observed that muscle quality control processes are impaired
with aging, but the precise effectors mediating this decline are
not yet clear.CAutophagy is an evolutionarily conserved recycling pathway
whereby cellular materials are engulfed into an autophagosome
and degraded through fusion with a lysosome (Vainshtein et al.,
2014). Macroautophagy (herein referred to as autophagy) is
robustly activated in response to nutrient deprivation (Mizushima
et al., 2004). Skeletal muscle is required to supply gluconeogenic
amino acids (such as alanine) for the maintenance of blood
glucose levels during prolonged fasting, a process known as
the glucose-alanine cycle (Felig et al., 1970). Autophagy is also
essential for the maintenance of skeletal muscle integrity as
mice with defects in this pathway exhibit muscle degeneration
and dysfunctional mitochondria, phenotypes that are accentu-
ated with aging (Masiero et al., 2009; Nemazanyy et al., 2013).
Thus, skeletal muscle autophagy is an essential process
required for maintaining muscle function andwhole-body energy
metabolism (Sandri, 2010).
The adenosine monophosphate-activated protein kinase
(AMPK) is an abg heterotrimeric protein kinase that responds to
energetic stress tomaintain energybalance throughphosphoryla-
tion of a diverse network of key metabolic pathways (Steinberg
andJørgensen, 2007). In skeletalmuscle, exercise, hormones, nu-
trients, and insulin sensitizing therapeutics havebeen shown to in-
crease AMPK activity. In contrast, the genetic removal of AMPK
from skeletal muscle dramatically reduces exercise capacity and
mitochondrial function (Lantier et al., 2014; O’Neill et al., 2011).
AMPK has recently been recognized as an activator of auto-
phagy that occurs through amulti-prongedmechanism involving
inhibition of the mammalian target of rapamycin (mTOR) com-
plex and direct activation/phosphorylation of Forkhead box O3
(FoxO3) and the Unc-51-like kinase 1 (Ulk1). Specifically,
AMPK inhibits mTOR through phosphorylation of TSC2 (Inoki
et al., 2003) and raptor (Gwinn et al., 2008) to promote the forma-
tion of an Ulk1-Atg13-FIP200 complex. AMPK phosphorylates
Beclin 1 to activate the pro-autophagy Vps34 complex and
inhibits the non-autophagy Vps34 complex (Kim et al., 2013a).
AMPK also promotes autophagy by activating FoxO3 (Sanchez
et al., 2012), which upregulates the transcription of numerous
muscle-specific atrogenes (Mammucari et al., 2007). Further,
AMPK directly activates both autophagy and mitophagy through
phosphorylation of Ulk1 at several primary sites, includingell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc. 883
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Figure 1. During Fasting, AMPK-MKO Mice Have Hypoglycemia, Hyperketosis, and Impaired Breakdown of Muscle
(A and B) Fatty acid oxidation (A) and blood glucose (B) during fasting (n = 6–12).
(C) Liver and gastrocnemius muscle glycogen (n = 5–6).
(D) ATT after 24 hr fast (n = 6–10).
(E and F) Serum alanine (E, n = 4–5) and serum b-hydroxybutyrate (F, n = 4–6). Data are means ± SEM.
(G) Myofiber CSA change of the TA muscle presented as median ± SEM (n = 4–6). * WT versus AMPK-MKO p < 0.05, **p < 0.01, # fed versus fasted p < 0.05,
## p < 0.01, ### p < 0.001. See also Figure S1 and Table S1.Ser555 (Egan et al., 2011), Ser317, and Ser777, while mTOR
inhibits this process via Ulk1 phosphorylation at Ser757 (Kim
et al., 2011).
In the current study, we investigated the importance of muscle
AMPK in controlling autophagy. We find that during prolonged
fasting, AMPK muscle-specific null (AMPK-MKO) mice fail to
induce sufficient autophagy and muscle breakdown to protect
against hypoglycemia and hyperketosis, indicating that muscle
AMPK is an essential component of the glucose-alanine cycle
(Felig et al., 1970). We also show that aged AMPK-MKO mice
have impaired muscle autophagy and develop a dramatic age-
associated myopathy and mitochondrial disease.
RESULTS
AMPK-MKOMice Have Impaired Muscle Wasting during
Fasting and Develop Hypoglycemia and Hyperketosis
During prolonged fasting, blood glucose levels aremaintained by
switching to fatty acid oxidation and breaking down skeletal
muscle for gluconeogenic substrates (Felig et al., 1970). Skeletal
muscle AMPK is activated by fasting, resulting in phosphoryla-
tion and inhibition of acetyl-CoA carboxylase 2 (ACC2), causing
a reduction in malonyl-CoA and an increase in fatty acid
oxidation (Steinberg and Jørgensen, 2007). Therefore, we fasted
mice lacking skeletal muscle AMPK (O’Neill et al., 2011) and884 Cell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc.mice with an ACC S212A knockin mutation (ACC2 KI) (O’Neill
et al., 2014), which have an impaired ability to regulate fatty
acid oxidation in muscle in response to pharmacological
AMPK activators such as AICAR. We found that both AMPK-
MKO (Figures 1A and S1A–S1C) and ACC2 KI mice (Figures
S1D–S1G) were able to adapt to this energetic stress by
increasing rates of fatty acid oxidation, while maintaining normal
voluntary activity levels (Figures S1H and S1I). These data indi-
cate that fasting-induced increases in fatty acid oxidation can
occur independent of AMPK/ACC2 signaling.
Despite normal rates of whole-body fatty acid oxidation, blood
glucose levels were significantly lower in fasted AMPK-MKO
(Figure 1B) but not ACC2 KI (Figure S1J) mice compared to
wild-type (WT) littermates. Hypoglycemia in AMPK-MKO mice
was not due to alterations in basal levels of muscle or liver
glycogen (Figure 1C). Serum lactate, glycerol, and non-esterified
fatty acids (NEFAs) were also not different between genotypes
(Table S1).
During prolonged fasting, alanine is a liver-specific gluconeo-
genic precursor that is used to maintain blood glucose (Felig
et al., 1970). We therefore conducted an alanine tolerance
test (ATT) following a 24 hr fast and found that while AMPK-
MKO mice had lower fasting blood glucose levels, injection
with alanine restored blood glucose in both WT and AMPK-MKO
mice (Figure 1D). These data indicate that liver gluconeogenesis
was not compromised in AMPK-MKO mice. We therefore hy-
pothesized that the impaired maintenance of blood glucose in
fasting AMPK-MKO mice might be due to an inability to supply
the liver with gluconeogenic substrates. Compared to WT
mice, alanine levels were dramatically reduced with fasting in
AMPK-MKO mice (Figure 1E). Consistent with lower serum
alanine levels and an inability to maintain gluconeogenesis, fast-
ing resulted in a 45-fold increase in serum b-hydroxybutyrate in
AMPK-MKO mice (Figure 1F).
Skeletal muscle contains the largest source of amino acids,
and during prolonged fasting, the gluconeogenic demands for
alanine are maintained by catabolizing muscle, resulting in a
reduction in muscle size (Sandri, 2010). We found that tibialis
anterior (TA) myofiber cross-sectional area (CSA) of WT mice
was reduced by 18% after a 48 hr fast (from 1,812 to
1,481 mm2), but the myofiber size of AMPK-MKO mice remained
unaffected (from 1,608 to 1,618 mm2) (Figure 1G). These findings
indicate that skeletal muscle AMPK is indispensable for acti-
vating muscle wasting to supply the essential gluconeogenic
amino acids that prevent hypoglycemia and hyperketosis.
AMPK-MKOMice Have Impaired Induction of Autophagy
with Fasting
Fasting-induced muscle wasting involves the induction of
autophagy; therefore, we tested the hypothesis that a lack of
skeletal muscle AMPK may have resulted in an inability to acti-
vate this pathway. Fasting increased activating phosphorylation
of AMPK at Thr172 and inhibitory phosphorylation of ACC (a
marker of AMPK activation) at Ser212 in WT but not AMPK-
MKO mice (Figures 2A–2C and Table S2), indicating that
AMPK activation is blocked in muscle of AMPK-MKO mice.
FoxO3 is activated by AMPK and is an important modulator of
muscle fiber size during prolonged fasting (Mammucari et al.,
2007; Sanchez et al., 2012). Since the transcriptional regulation
ofmuscle atrophy precedesmuscle loss, we investigated protein
and mRNA expression of the FoxO3 pathway at 12 and 24 hr of
fasting in addition to the 48 hr time point. Fasting increased total
FoxO3 expression, and there was a main effect of higher total
and phosphorylated FoxO3 at Ser413 in the AMPK-MKO mice
(Figures S2A–S2C); however, phosphorylation of FoxO3
Ser413/FoxO3 was not different between genotypes (Figures
S2A and S2D). The muscle-specific atrophy protein and FoxO3
target Bnip3 was, however, significantly lower in AMPK-MKO
mice in response to fasting (Figure 2D). Protein expression
of another muscle-specific atrophy protein and primary FoxO3
transcriptional target, Atrogin1, was increased with fasting inde-
pendent of genotype (Figures S2A and S2E). A third FoxO3
target, MuRF1, showed no changes in response to fasting in
either genotype (Figures S2A and S2F). The mRNA expression
of these FoxO3 family members increased with fasting as ex-
pected, but no differences were detected between WT and
AMPK-MKO mice (Figure S2G). Since mitochondrial shaping
dynamics have been shown to regulate muscle atrophy via the
AMPK-FoxO3 axis (Romanello et al., 2010), we investigated
themRNA expression of primarymitochondrial fission and fusion
proteins. Mitofusin 1 expression was significantly lower in fed
AMPK-MKOmice and there was amain genotype effect of lower
mitofusin 2, but other related transcripts were not altered (Fig-
ure S2H). Increased PGC1a has been shown to inhibit muscleCatrophy by blocking autophagy (Cannavino et al., 2014), but
this was not altered in the AMPK-MKOmice (Figure S2H). These
data indicate that during fasting AMPK is required for the induc-
tion of the FoxO3 transcriptional target and autophagy protein
Bnip3, but that AMPK is not essential for the control of all
FoxO3 targets.
mTOR and Ulk1 form a unified feedback loop that reciprocally
regulates protein balance through the control of synthetic path-
ways and the initial steps of autophagosome formation (Egan
et al., 2011; Kim et al., 2011). To determine if mTOR was acti-
vated in AMPK-MKOmice, wemeasured the downstream target
S6 kinase (S6K) and found a significant main effect of elevated
S6K Thr389 phosphorylation/total S6K in AMPK-MKO mice
(Figure 2E). Activated Ulk1 forms an isolation membrane, which
is an essential first step in autophagosome formation (Vainshtein
et al., 2014). Fasting increased the expression of total Ulk1, but
this was independent of AMPK (Figures 2A and 2F). In contrast,
Ulk1 Ser555 phosphorylation mirrored changes in AMPK activ-
ity, in that it was lower in AMPK-MKOmice under fed and fasted
conditions and increased in fasted WT but not AMPK-MKOmice
(Figures 2A, 2G, and 2H). Phosphorylation of Ulk1 at Ser317/total
Ulk1 showed no differences between genotypes or fasting (Fig-
ures 2A and Table S2). There was also a main effect of higher
phosphorylation of Ulk1 at the mTOR-dependent inhibitory site
Ser757 in AMPK-MKO compared to WT mice (Figures 2A and
2I). These findings support the concept that AMPK activation
of Ulk1 likely involves direct and indirect mechanisms including
both the phosphorylation of Ser555 and the prevention of inhib-
itory mTOR phosphorylation at Ulk1 Ser757.
Lipidation of LC3 is one of the last essential steps in the forma-
tion of an activated autophagosome and is considered one of the
most reliable markers of autophagy (Kabeya et al., 2000). To
examine whether this parameter was altered, the TA muscle
was electroporatedwith fluorescently tagged LC3 prior to fasting
for 48 hr. The accumulation of RFP-LC3 puncta represents
active autophagosomes aggregating during autophagy and
was not different between genotypes under fed conditions, a
finding consistent with low levels of AMPK activity and unaltered
basal autophagy. However, during fasting RFP-LC3 puncta were
increased in WT but not AMPK-MKO littermates (Figures 3A and
3B). This effect was not observed with an empty RFP construct
(Figure S2I). To confirm that the lower amount of LC3 puncta in
AMPK-MKOmice is not due to the exhaustive degradation of au-
tophagosomes, we injected mice with colchicine (for 2 days),
which prevents autophagic flux by inhibiting autophagosome-
lysosome fusion in skeletal muscle (Ju et al., 2010). LC3 lipida-
tion was not altered in response to colchicine treatment during
the fed condition, suggesting basal-general autophagic flux
was not altered. However, WTmice did experience the expected
increase in LC3 lipidation with fasting (as determined by the ratio
of LC3II/LC3I) and a substantially greater increase when injected
with colchicine prior to fasting (Figure 3C). Importantly, these
changes were absent in AMPK-MKO mice.
Analysis of the individual LC3 isoforms showed that WT mice
had the expected reduction in LC3I (Figure S2J) and increase in
LC3II (Figure S2K) observed with fasting and colchicine, consis-
tent with activation of autophagy. In contrast, AMPK-MKO mice
had increased LC3I and LC3II with colchicine treatment during
fasting. This finding of simultaneously higher LC3I and LC3II inell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc. 885
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Figure 2. AMPK-MKO Mice Fail to Induce Autophagy Signaling in Response to Fasting
(A) Representative western blots from TA muscle.
(B–I)Analysis of western blots for the following proteins: (B) AMPK Thr172 (n = 3–6), (C) ACC Ser212/ACC (n = 6–8), (D) Bnip3 (n = 5–12), (E) S6K Thr389/S6K
(n = 5–12), (F) Ulk1 Total (n = 6–8), (G) Ulk1 Ser555 (n = 6–8), (H) Ulk1 Ser555/Ulk1 (n = 6–8), and (I) Ulk1 Ser757/Ulk1 (n = 5–8).
Data are means ± SEM. * WT versus AMPK-MKO p < 0.05, **p < 0.01, ***p < 0.001, # fed versus fasted p < 0.05, ### p < 0.001, ymain effect of genotype p < 0.05,
yy p < 0.01, yyy p < 0.001, x main effect of fasting p < 0.05. See also Figure S2 and Table S2.AMPK-MKOmicemirrors othermousemodels with reductions in
autophagic flux including muscle-specific HDAC1/2 KO mice
(Moresi et al., 2012) and in WT mice given colchicine for886 Cell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc.extended periods (beyond 5 days) (Ju et al., 2010). Since LC3
mRNA expression was indistinguishable between genotypes
during fed, fasting, and colchicine treatments (Figure S2L), these
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Figure 3. AMPK-MKO Mice Have Impaired Autophagic Flux in Response to Fasting
(A and B) Photomicrographs (A, scale bar, 10 mm) and quantification (B, n = 3–4) of RFP-LC3 puncta in TA muscle.
(C and D) LC3II/LC3I expression in mice treated with sterile water or colchicine (C, n = 9–19) and Parkin expression (D, n = 4–5).
(E and F) Photomicrographs of Parkin (scale bar, 10 mm), Tom20, and merged image (scale bar, 1 mm) (n = 3 per group) (E) and quantification in TA muscle (F).
Data aremeans ± SEM. *WT versus AMPK-MKOp< 0.05, **p < 0.01, ***p < 0.001, ### fed versus fasted p < 0.001, F F F fast saline versus fast colchicine p < 0.001.data point to AMPK-MKO mice having increased LC3 protein
stability in response to a blockade in autophagic flux.
Protein and mRNA expression of the autophagy adaptor
protein p62 was increased with fasting, but was not different be-
tween genotypes or with colchicine treatment (Figures S2M and
S2N). Corresponding with a reduction in autophagic flux, accu-
mulation of the mitophagy protein Parkin, a protein that tags
dysfunctional mitochondria for degradation, was over 2-fold
higher in both the fed and fasted AMPK-MKO mice (Figure 3D).
As the mRNA expression of Parkin was similar between geno-
types (Figure S2O), this indicates that the accumulation of this
protein in AMPK-MKO mice is due to the impaired removal of
mitochondria tagged for degradation. This finding was further
corroborated by immunostaining for Parkin and the mitochon-
drial protein Tom20 in TA muscle, which demonstrated an 2.5
fold greater accumulation of Parkin in both fed and fasted
AMPK-MKO mice and the co-localization of this protein with
mitochondria (Figures 3E and 3F). These data indicate that skel-Cetal muscle AMPK is required for the maintenance of basal
mitophagy and for the induction of autophagy and mitophagy
during fasting.
AMPK-MKO Mice Experience Severe Age-Related
Myopathy and Mitochondrial Disease
Although acute metabolic stressors like nutrient deprivation
strongly induce autophagy, tissues undergo a basal-level of
autophagic flux even during nutrient abundance in order to
recycleolder proteins andmaintainquality control for thosenewly
synthesized (Mizushima et al., 2004). Aging reduces autophagic
flux and mitochondrial function, effects that have been associ-
ated with lower skeletal muscle AMPK activity (Salminen and
Kaarniranta, 2012). We therefore examined whether a loss of
muscle AMPK may promote aging-induced muscle dysfunction
and found that in the absence of AMPK, TAmuscles hadmore fi-
bers containing centrally located nuclei (Figure 4A), accumulated
more collagen (Figure 4B), and had a greater number of largeell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc. 887
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Figure 4. Aged AMPK-MKO Mice Develop Exacerbated Myopathy and Mitochondrial Disease
(A) Percent of fibers with centrally located nuclei (n = 4–10) and (B) collagen accumulation (n = 3–10) in TA muscle.
(C–K) Aged AMPK-MKO and WT mice. (C) Photomicrograph (scale bar, 100 mm) showing large rounded fibers (closed arrow), small angular fibers (open arrow),
and necrotic fibers (asterisk) in TA. (D) Maximum isometric and (E) specific force production of TA muscle (n = 4–6). (F) Percent adiposity with representative CT
images (n = 4–7). Mitochondrial size in the (G) IMF and (H) SS regions of the myofiber (n = 3 per group). Number of mitochondria in the (I) IMF and (J) SS myofiber
regions (n = 3 per group). (K) Representative electronmicrograph showing enlarged mitochondria (closed arrow) (scale bar, 4 mm).
(L and M) Number of mtDNA copies (L, n = 6–9) and mtDNA deletions (M, n = 5–10) in quadriceps muscle.
(N and O) p62 (N) and Parkin (O, n = 7–11) expression in extensor digitorum longus muscle in fed state.
Data are means ± SEM. * WT versus AMPK-MKO p < 0.05, **p < 0.01, ***p < 0.001, # fed versus fasted p < 0.05, ## p < 0.01, ### p < 0.001.rounded fibers, small angular fibers, and necrotic fibers than
agedWT littermates (Figure 4C). Consistent with the dramatic re-
ductions in muscle quality, aged AMPK-MKO mice had lower
maximal and specific force production, indicating impaired mus-
cle function compared to aged WT littermates (Figures 4D and
4E). In contrast young-adult WT and AMPK-MKO mice had
comparable maximal force production (WT = 923.8 ± 20.5 mN,
AMPK-MKO = 931.4 ± 28.4 mN, n = 8). Cardiac cachexia can
contribute to muscle weakness/atrophy and is characterized by
cardiac hypertrophy, increased circulating inflammatorymarkers
such as TNF-a, IL-6, and IL-1b, and loss of adipose tissue and
lean mass (Anker and Sharma, 2002). We found that cardiac
mass (WT = 139.8 ± 4.4 mg, n = 4, AMPK-MKO = 139.9 ±
5.0 mg, n = 6), systemic inflammation (Figure S2P), and
adiposity/lean mass (Figure 4F) were all comparable between
aged WT and AMPK-MKO mice. These data indicate that
AMPK-MKO mice have an age-related myopathy that impairs
muscle function that is unlikely the result of cardiac cachexia.888 Cell Metabolism 21, 883–890, June 2, 2015 ª2015 Elsevier Inc.Alterations in mitophagy are thought to result in the decline
of mitochondrial content and quality with aging (Terman et al.,
2010). Electron microscopy imaging revealed that the average
size of mitochondria from both the intermyofibrillar (IMF) and sub-
sarcolemmal (SS) regionswere twice as large inagedAMPK-MKO
mice compared to WT (Figures 4G and 4H). Aged AMPK-MKO
mice also had a substantially lower number of mitochondria
present in the IMF and SS regions (27% and 51%, respectively)
(Figures 4I–4K) and reduced mitochondrial DNA (mtDNA) copy
number (Figure 4L), consistent with what is seen in human aging
(Crane et al., 2010). These changes in mitochondrial size were
much more dramatic than we have observed previously in young
adult AMPK-MKO (O’Neill et al., 2011). Mutations in mtDNA are
linked to mitochondrial disease (Park and Larsson, 2011) and we
found that aged AMPK-MKOmice had significantly more mtDNA
deletions than young AMPK-MKOmice (Figure 4M). Aged ad libi-
tum-fed AMPK-MKO mice also had a 2-fold increase in p62 and
Parkin accumulation, suggesting that basal autophagic clearance
of mitochondria is chronically impaired in muscle of these mice
(Figures 4N and 4O). These findings identify that muscle AMPK
is essential to prevent aging-associated myopathy.
DISCUSSION
Autophagy is an essential mediator of cellular maintenance,
particularly in tissues containing long-lived post-mitotic cells
such as muscle. Skeletal muscles serve as the largest reserve
of protein in the body. In periods of prolonged fasting, alanine
is the primary amino acid to be released peripherally frommuscle
and converted into glucose within the liver during the glucose-
alanine cycle (Felig et al., 1970). The deletion of muscle AMPK
activity prevented mice from fasting-induced muscle wasting,
resulting in lower levels of serum alanine and blood glucose
and the development of hyperketosis. Since increased ACC ac-
tivity caused by the loss of muscle AMPK could potentially lower
fatty acid oxidation in thesemice, we also determined the fasting
response in ACC2 KI mice, but found that these mice did not
develop hypoglycemia, suggesting the hypoglycemia observed
in AMPK-MKO mice is due to lower amino acid availability and
not from altered fatty acid metabolism.
In order to identify the mechanisms by which skeletal muscle
AMPK prevents fasting-induced hypoglycemia, hyperketosis,
and reductions in muscle size, we assessed the localization of
LC3, a protein that is required for autophagosome activation
(Kabeya et al., 2000). We found that fastedWTmice had a signif-
icantly higher amount of RFP-LC3 puncta compared to AMPK-
MKO mice. Reduced LC3 puncta in combination with the lower
state of autophagic flux observed in AMPK-MKO mice indicates
that in the absence of AMPK there is impaired autophagosome
formation and induction of autophagy during fasting. AMPK has
been shown to regulate both autophagy and mitophagy in liver
cells via phosphorylation of Ulk1 at Ser555 in addition to three
other AMPK-dependent sites (Egan et al., 2011). In agreement
with this study, we found that onlyWTmice increased phosphor-
ylation at the Ser555 site in response to fasting and that the ratio
of Ser555/total Ulk1 was substantially decreased in fed and
fasted AMPK-MKOmice. mTOR has also been found to regulate
autophagy via inhibitory Ulk1 phosphorylation at Ser757 (Castets
et al., 2013; Kim et al., 2011). Consistent with these reports, we
found AMPK-MKO mice had higher activation of mTOR and
greater inhibitory phosphorylation ofUlk1 at Ser757. Additionally,
we observed lower Bnip3 and prevention of fasting-induced
muscle loss in AMPK-MKO mice. This supports the findings of
Romanello et al. that overexpression of FoxO3 and its target
protein Bnip3 activated autophagy and muscle atrophy in an
AMPK-dependent manner (Romanello et al., 2010). In addition,
liver-specific deletion of the autophagy protein Atg7 also lowers
serum amino acids and results in hypoglycemia (Ezaki et al.,
2011). Thus, it appears that both skeletal muscle and liver auto-
phagy are required to provide amino acids to sustain hepatic
gluconeogenesis during prolonged food deprivation.
Aging is commonly associated with muscle wasting (sarcope-
nia), inappropriate fiber repair, and mitochondrial dysfunction
(Johnson et al., 2013). Aged AMPK-MKO mice have increased
centrally located nuclei, increased muscle collagen, and
impaired muscle function compared to WT. These features
resemble the accelerated age-inducedmyopathy andmitochon-Cdrial dysfunction observed in mice lacking Atg7 in muscle
(Carnio et al., 2014; Masiero et al., 2009). In parallel to the pro-
nounced myopathy, the mitochondria of aged AMPK-MKO
mice have an aberrant enlarged morphology and an increased
amount of mtDNA deletions, indicative of accelerated mito-
chondrial dysfunction. This mitochondrial phenotype of aged
AMPK-MKO mice resembles effects seen in TSC-1-deficient
mice, which have chronically impaired autophagy due to hyper-
activation of mTORC1 (Castets et al., 2013) and with muscular
dystrophy (Grumati and Bonaldo, 2012).
In summary,wedemonstrate theessential roleofmuscleAMPK
in regulating autophagy and glucose homeostasis during pro-
longed fasting and limiting aging-induced muscle and mitochon-
drial dysfunction. We show that this is likely mediated via directly
phosphorylating Ulk1 at Ser555 and by indirectly blocking mTOR
inhibitory Ulk1 phosphorylation at Ser757. These studies provide
an important molecular link between muscle breakdown/alanine
release and gluconeogenesis originally described by the Cahill
laboratory (Felig et al., 1970). In addition, as aging is associated
with reduced skeletal muscle AMPK (Reznick et al., 2007) and
reduced autophagic function (Kim et al., 2013b), our studies
suggest that activation of AMPK may be beneficial in mitigating
aging-induced reductions in muscle function.
EXPERIMENTAL PROCEDURES
A detailed description of all methods can be found in the Supplemental Exper-
imental Procedures. Briefly, all animal studies were approved by McMaster’s
Animal Research Ethics Board (AUP #12-12-44). AMPK-MKO mice (O’Neill
et al., 2011) were studied at 2 (young) or 18 (aged) months of age. ACC2 KI
mice (Fullerton et al., 2013) were studied at 5 months of age. For fasting exper-
iments, food was removed for a total of 12, 24, or 48 hr prior to sacrifice and
tissue collection. ATT was performed following a 24 hr fast by injecting
2 g/kg L-alanine (Sigma) in PBS intraperitoneally (i.p.). Autophagic flux was
evaluated following i.p. injection with 100 ml of either sterile water (control) or
colchicine (0.4 mg/kg/day) daily for 2 days. TA muscles were electroporated
with tandem fluorescent-tagged LC3 plasmid or RFP plasmid, and tissues
were collected 5 days later. Contractile properties of the TA muscle were
measured in situ. Immunostaining, transmission electron microscopy, western
blotting, andRT-qPCRconditions and reagents used are described in the Sup-
plemental Experimental Procedures. Serum metabolites and cytokines were
measured according to manufacturer’s instructions. Liver and muscle
glycogen were determined via acid hydrolysis and colorimetric detection of
glucose. mtDNA copy number and deletions were assessed using primers
targeted to the Nd1, Nd4, and b-globin genes. All statistical analysis was per-
formed using Student’s t test or two-way ANOVA as appropriate on GraphPad
Prism 5. p < 0.05 was considered statistically significant. Data are presented
as mean ± SEM except where stated otherwise.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.05.016.
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